Candel Therapeutics Gets FDA's Orphan-Drug Status for Glioma Treatment Global News Select May 30, 2024 12:45pm
Candel Therapeutics Shares Leap Premarket on FDA Orphan-Drug Designation Global News Select Apr 11, 2024 1:30pm
Candel Therapeutics stock jumps as pancreatic cancer treatment shows promise MarketWatch Apr 5, 2024 12:56pm
Candel Gets FDA Fast-Track Designation for CAN-3110 in Recurrent High-Grade Glioma Global News Select Feb 13, 2024 1:03pm
Candel Therapeutics Shares Soar After FDA Fast Track of CAN-2409 Global News Select Dec 12, 2023 1:43pm